Key blood-clotting factor found in zebrafish model
Scientists here have
found the first evidence of a key blood-clotting agent, factor VII, in
zebrafish. The finding by researchers at The University of Texas Health Science
Center at San Antonio (UTHSC) further establishes the credibility of the
zebrafish as a relevant model for studying human blood clotting.
“It is critical to show that the clotting cascade in
zebrafish is very similar to human clotting so that zebrafish studies will have
clinical relevance,” said Pudur Jagadeeswaran, Ph.D., associate professor of
cellular and structural biology at UTHSC. The finding is reported in the July
17 online posting of Proceedings of the National Academy of Sciences at www.pnas.org/cgi/content/full/98/15/8768.
Scientists theorized the existence of zebrafish factor
VII for more than three decades. Dr. Russell F. Doolittle, research professor
at The University of California, San Diego, first proposed the idea in the
1960s. Dr. Jagadeeswaran’s research team used recombinant DNA technology to
create a zebrafish factor VII deficiency plasma, a substance that will not clot
because factor VII is missing. The team repeated the experiment with a human
factor VII deficiency plasma.
“This is a
credible coagulation-initiation model,” Dr. Jagadeeswaran said. “Such studies
could be important in development of new stroke-prevention drugs.”
Dr. Jagadeeswaran is one of 30 zebrafish researchers
nationwide who will convene at UTHSC on July 26 and 27 for the Texas Zebrafish
Development and Genetics Meeting.
Reporters: Side-by-side figures comparing factor VII in
zebrafish and humans are available.
Contact: Will Sansom